nodes	percent_of_prediction	percent_of_DWPC	metapath
Zuclopenthixol—HTR6—Raloxifene—osteoporosis	0.365	0.881	CbGbCtD
Zuclopenthixol—CYP2D6—Cholecalciferol—osteoporosis	0.0492	0.119	CbGbCtD
Zuclopenthixol—Hyperhidrosis—Pamidronate—osteoporosis	0.000478	0.000958	CcSEcCtD
Zuclopenthixol—Syncope—Conjugated Estrogens—osteoporosis	0.000478	0.000958	CcSEcCtD
Zuclopenthixol—Hypertension—Zoledronate—osteoporosis	0.000478	0.000957	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Alendronate—osteoporosis	0.000478	0.000957	CcSEcCtD
Zuclopenthixol—Headache—Etidronic acid—osteoporosis	0.000477	0.000955	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000474	0.00095	CcSEcCtD
Zuclopenthixol—Asthenia—Estropipate—osteoporosis	0.000472	0.000946	CcSEcCtD
Zuclopenthixol—Visual impairment—Estradiol—osteoporosis	0.000472	0.000946	CcSEcCtD
Zuclopenthixol—Anorexia—Pamidronate—osteoporosis	0.000471	0.000944	CcSEcCtD
Zuclopenthixol—Myalgia—Zoledronate—osteoporosis	0.000471	0.000944	CcSEcCtD
Zuclopenthixol—Palpitations—Conjugated Estrogens—osteoporosis	0.000471	0.000944	CcSEcCtD
Zuclopenthixol—Insomnia—Risedronate—osteoporosis	0.00047	0.000943	CcSEcCtD
Zuclopenthixol—Anxiety—Zoledronate—osteoporosis	0.000469	0.000941	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000468	0.000939	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000468	0.000938	CcSEcCtD
Zuclopenthixol—Paraesthesia—Risedronate—osteoporosis	0.000467	0.000936	CcSEcCtD
Zuclopenthixol—Pruritus—Estropipate—osteoporosis	0.000466	0.000933	CcSEcCtD
Zuclopenthixol—Discomfort—Zoledronate—osteoporosis	0.000465	0.000933	CcSEcCtD
Zuclopenthixol—Asthenia—Alendronate—osteoporosis	0.000465	0.000932	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Ibandronate—osteoporosis	0.000465	0.000932	CcSEcCtD
Zuclopenthixol—Dyspnoea—Risedronate—osteoporosis	0.000464	0.000929	CcSEcCtD
Zuclopenthixol—Hypotension—Pamidronate—osteoporosis	0.000462	0.000926	CcSEcCtD
Zuclopenthixol—Convulsion—Conjugated Estrogens—osteoporosis	0.000462	0.000925	CcSEcCtD
Zuclopenthixol—Dry mouth—Zoledronate—osteoporosis	0.000461	0.000923	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000461	0.000923	CcSEcCtD
Zuclopenthixol—Fatigue—Ethinyl Estradiol—osteoporosis	0.00046	0.000922	CcSEcCtD
Zuclopenthixol—Pruritus—Alendronate—osteoporosis	0.000459	0.000919	CcSEcCtD
Zuclopenthixol—Dyspepsia—Risedronate—osteoporosis	0.000458	0.000918	CcSEcCtD
Zuclopenthixol—Eye disorder—Estradiol—osteoporosis	0.000458	0.000917	CcSEcCtD
Zuclopenthixol—Tinnitus—Estradiol—osteoporosis	0.000457	0.000915	CcSEcCtD
Zuclopenthixol—Constipation—Ethinyl Estradiol—osteoporosis	0.000456	0.000914	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Calcitriol—osteoporosis	0.000455	0.000912	CcSEcCtD
Zuclopenthixol—Cardiac disorder—Estradiol—osteoporosis	0.000455	0.000911	CcSEcCtD
Zuclopenthixol—Myalgia—Conjugated Estrogens—osteoporosis	0.000454	0.000909	CcSEcCtD
Zuclopenthixol—Asthenia—Ibandronate—osteoporosis	0.000453	0.000907	CcSEcCtD
Zuclopenthixol—Anxiety—Conjugated Estrogens—osteoporosis	0.000452	0.000906	CcSEcCtD
Zuclopenthixol—Nausea—Etidronic acid—osteoporosis	0.000452	0.000906	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Zoledronate—osteoporosis	0.000452	0.000905	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.00045	0.000903	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.00045	0.000903	CcSEcCtD
Zuclopenthixol—Diarrhoea—Estropipate—osteoporosis	0.00045	0.000902	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Risedronate—osteoporosis	0.000449	0.0009	CcSEcCtD
Zuclopenthixol—Fatigue—Risedronate—osteoporosis	0.000448	0.000899	CcSEcCtD
Zuclopenthixol—Insomnia—Pamidronate—osteoporosis	0.000447	0.000896	CcSEcCtD
Zuclopenthixol—Pruritus—Ibandronate—osteoporosis	0.000446	0.000895	CcSEcCtD
Zuclopenthixol—Pain—Risedronate—osteoporosis	0.000445	0.000891	CcSEcCtD
Zuclopenthixol—Constipation—Risedronate—osteoporosis	0.000445	0.000891	CcSEcCtD
Zuclopenthixol—Angiopathy—Estradiol—osteoporosis	0.000444	0.000891	CcSEcCtD
Zuclopenthixol—Shock—Zoledronate—osteoporosis	0.000444	0.00089	CcSEcCtD
Zuclopenthixol—Paraesthesia—Pamidronate—osteoporosis	0.000444	0.00089	CcSEcCtD
Zuclopenthixol—Diarrhoea—Alendronate—osteoporosis	0.000443	0.000889	CcSEcCtD
Zuclopenthixol—Asthenia—Calcitriol—osteoporosis	0.000443	0.000888	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Zoledronate—osteoporosis	0.000443	0.000888	CcSEcCtD
Zuclopenthixol—Immune system disorder—Estradiol—osteoporosis	0.000442	0.000887	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Zoledronate—osteoporosis	0.000442	0.000886	CcSEcCtD
Zuclopenthixol—Dyspnoea—Pamidronate—osteoporosis	0.000441	0.000883	CcSEcCtD
Zuclopenthixol—Tachycardia—Zoledronate—osteoporosis	0.000441	0.000883	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00044	0.000881	CcSEcCtD
Zuclopenthixol—Somnolence—Pamidronate—osteoporosis	0.00044	0.000881	CcSEcCtD
Zuclopenthixol—Skin disorder—Zoledronate—osteoporosis	0.000439	0.000879	CcSEcCtD
Zuclopenthixol—Pruritus—Calcitriol—osteoporosis	0.000437	0.000876	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Zoledronate—osteoporosis	0.000437	0.000875	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000436	0.000874	CcSEcCtD
Zuclopenthixol—Diarrhoea—Raloxifene—osteoporosis	0.000436	0.000874	CcSEcCtD
Zuclopenthixol—Dyspepsia—Pamidronate—osteoporosis	0.000435	0.000872	CcSEcCtD
Zuclopenthixol—Dizziness—Estropipate—osteoporosis	0.000435	0.000872	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000435	0.000871	CcSEcCtD
Zuclopenthixol—Diarrhoea—Ibandronate—osteoporosis	0.000432	0.000865	CcSEcCtD
Zuclopenthixol—Anorexia—Zoledronate—osteoporosis	0.00043	0.000863	CcSEcCtD
Zuclopenthixol—Decreased appetite—Pamidronate—osteoporosis	0.00043	0.000861	CcSEcCtD
Zuclopenthixol—Mental disorder—Estradiol—osteoporosis	0.000429	0.00086	CcSEcCtD
Zuclopenthixol—Dizziness—Alendronate—osteoporosis	0.000429	0.000859	CcSEcCtD
Zuclopenthixol—Shock—Conjugated Estrogens—osteoporosis	0.000428	0.000857	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000427	0.000855	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000426	0.000855	CcSEcCtD
Zuclopenthixol—Malnutrition—Estradiol—osteoporosis	0.000426	0.000855	CcSEcCtD
Zuclopenthixol—Erythema—Estradiol—osteoporosis	0.000426	0.000855	CcSEcCtD
Zuclopenthixol—Fatigue—Pamidronate—osteoporosis	0.000426	0.000854	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Risedronate—osteoporosis	0.000425	0.000852	CcSEcCtD
Zuclopenthixol—Tachycardia—Conjugated Estrogens—osteoporosis	0.000424	0.000851	CcSEcCtD
Zuclopenthixol—Pain—Pamidronate—osteoporosis	0.000423	0.000847	CcSEcCtD
Zuclopenthixol—Constipation—Pamidronate—osteoporosis	0.000423	0.000847	CcSEcCtD
Zuclopenthixol—Diarrhoea—Calcitriol—osteoporosis	0.000423	0.000847	CcSEcCtD
Zuclopenthixol—Skin disorder—Conjugated Estrogens—osteoporosis	0.000422	0.000846	CcSEcCtD
Zuclopenthixol—Hypotension—Zoledronate—osteoporosis	0.000422	0.000846	CcSEcCtD
Zuclopenthixol—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000422	0.000845	CcSEcCtD
Zuclopenthixol—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000422	0.000845	CcSEcCtD
Zuclopenthixol—Dizziness—Raloxifene—osteoporosis	0.000422	0.000845	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00042	0.000842	CcSEcCtD
Zuclopenthixol—Flatulence—Estradiol—osteoporosis	0.00042	0.000842	CcSEcCtD
Zuclopenthixol—Tension—Estradiol—osteoporosis	0.000418	0.000839	CcSEcCtD
Zuclopenthixol—Vomiting—Estropipate—osteoporosis	0.000418	0.000839	CcSEcCtD
Zuclopenthixol—Dizziness—Ibandronate—osteoporosis	0.000417	0.000836	CcSEcCtD
Zuclopenthixol—Rash—Estropipate—osteoporosis	0.000415	0.000832	CcSEcCtD
Zuclopenthixol—Dermatitis—Estropipate—osteoporosis	0.000415	0.000831	CcSEcCtD
Zuclopenthixol—Anorexia—Conjugated Estrogens—osteoporosis	0.000414	0.000831	CcSEcCtD
Zuclopenthixol—Nervousness—Estradiol—osteoporosis	0.000414	0.00083	CcSEcCtD
Zuclopenthixol—Headache—Estropipate—osteoporosis	0.000412	0.000826	CcSEcCtD
Zuclopenthixol—Vomiting—Alendronate—osteoporosis	0.000412	0.000826	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000411	0.000825	CcSEcCtD
Zuclopenthixol—Abdominal pain—Risedronate—osteoporosis	0.000411	0.000824	CcSEcCtD
Zuclopenthixol—Body temperature increased—Risedronate—osteoporosis	0.000411	0.000824	CcSEcCtD
Zuclopenthixol—Rash—Alendronate—osteoporosis	0.000409	0.000819	CcSEcCtD
Zuclopenthixol—Insomnia—Zoledronate—osteoporosis	0.000408	0.000819	CcSEcCtD
Zuclopenthixol—Dermatitis—Alendronate—osteoporosis	0.000408	0.000818	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Pamidronate—osteoporosis	0.000407	0.000817	CcSEcCtD
Zuclopenthixol—Hypotension—Conjugated Estrogens—osteoporosis	0.000406	0.000814	CcSEcCtD
Zuclopenthixol—Headache—Alendronate—osteoporosis	0.000406	0.000814	CcSEcCtD
Zuclopenthixol—Paraesthesia—Zoledronate—osteoporosis	0.000405	0.000813	CcSEcCtD
Zuclopenthixol—Vomiting—Raloxifene—osteoporosis	0.000405	0.000812	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Pamidronate—osteoporosis	0.000404	0.00081	CcSEcCtD
Zuclopenthixol—Dyspnoea—Zoledronate—osteoporosis	0.000403	0.000807	CcSEcCtD
Zuclopenthixol—Rash—Raloxifene—osteoporosis	0.000402	0.000806	CcSEcCtD
Zuclopenthixol—Dermatitis—Raloxifene—osteoporosis	0.000402	0.000805	CcSEcCtD
Zuclopenthixol—Somnolence—Zoledronate—osteoporosis	0.000401	0.000805	CcSEcCtD
Zuclopenthixol—Vomiting—Ibandronate—osteoporosis	0.000401	0.000804	CcSEcCtD
Zuclopenthixol—Tremor—Estradiol—osteoporosis	0.0004	0.000801	CcSEcCtD
Zuclopenthixol—Headache—Raloxifene—osteoporosis	0.000399	0.0008	CcSEcCtD
Zuclopenthixol—Rash—Ibandronate—osteoporosis	0.000398	0.000797	CcSEcCtD
Zuclopenthixol—Dermatitis—Ibandronate—osteoporosis	0.000398	0.000797	CcSEcCtD
Zuclopenthixol—Dyspepsia—Zoledronate—osteoporosis	0.000398	0.000797	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000396	0.000794	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Estradiol—osteoporosis	0.000396	0.000793	CcSEcCtD
Zuclopenthixol—Headache—Ibandronate—osteoporosis	0.000395	0.000792	CcSEcCtD
Zuclopenthixol—Insomnia—Conjugated Estrogens—osteoporosis	0.000393	0.000788	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000393	0.000788	CcSEcCtD
Zuclopenthixol—Vomiting—Calcitriol—osteoporosis	0.000393	0.000787	CcSEcCtD
Zuclopenthixol—Decreased appetite—Zoledronate—osteoporosis	0.000393	0.000787	CcSEcCtD
Zuclopenthixol—Agitation—Estradiol—osteoporosis	0.000392	0.000785	CcSEcCtD
Zuclopenthixol—Nausea—Estropipate—osteoporosis	0.000391	0.000783	CcSEcCtD
Zuclopenthixol—Abdominal pain—Pamidronate—osteoporosis	0.000391	0.000783	CcSEcCtD
Zuclopenthixol—Body temperature increased—Pamidronate—osteoporosis	0.000391	0.000783	CcSEcCtD
Zuclopenthixol—Paraesthesia—Conjugated Estrogens—osteoporosis	0.00039	0.000783	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00039	0.000781	CcSEcCtD
Zuclopenthixol—Rash—Calcitriol—osteoporosis	0.000389	0.000781	CcSEcCtD
Zuclopenthixol—Fatigue—Zoledronate—osteoporosis	0.000389	0.00078	CcSEcCtD
Zuclopenthixol—Dermatitis—Calcitriol—osteoporosis	0.000389	0.00078	CcSEcCtD
Zuclopenthixol—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000388	0.000777	CcSEcCtD
Zuclopenthixol—Headache—Calcitriol—osteoporosis	0.000387	0.000776	CcSEcCtD
Zuclopenthixol—Somnolence—Conjugated Estrogens—osteoporosis	0.000387	0.000775	CcSEcCtD
Zuclopenthixol—Constipation—Zoledronate—osteoporosis	0.000386	0.000774	CcSEcCtD
Zuclopenthixol—Pain—Zoledronate—osteoporosis	0.000386	0.000774	CcSEcCtD
Zuclopenthixol—Nausea—Alendronate—osteoporosis	0.000385	0.000772	CcSEcCtD
Zuclopenthixol—Malaise—Estradiol—osteoporosis	0.000385	0.000771	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Risedronate—osteoporosis	0.000383	0.000768	CcSEcCtD
Zuclopenthixol—Vertigo—Estradiol—osteoporosis	0.000383	0.000768	CcSEcCtD
Zuclopenthixol—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000383	0.000767	CcSEcCtD
Zuclopenthixol—Asthenia—Ethinyl Estradiol—osteoporosis	0.000383	0.000767	CcSEcCtD
Zuclopenthixol—Syncope—Estradiol—osteoporosis	0.000382	0.000766	CcSEcCtD
Zuclopenthixol—Nausea—Raloxifene—osteoporosis	0.000379	0.000759	CcSEcCtD
Zuclopenthixol—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000378	0.000758	CcSEcCtD
Zuclopenthixol—Pruritus—Ethinyl Estradiol—osteoporosis	0.000377	0.000756	CcSEcCtD
Zuclopenthixol—Palpitations—Estradiol—osteoporosis	0.000377	0.000755	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000375	0.000752	CcSEcCtD
Zuclopenthixol—Fatigue—Conjugated Estrogens—osteoporosis	0.000375	0.000751	CcSEcCtD
Zuclopenthixol—Nausea—Ibandronate—osteoporosis	0.000375	0.000751	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Estradiol—osteoporosis	0.000375	0.000751	CcSEcCtD
Zuclopenthixol—Asthenia—Risedronate—osteoporosis	0.000373	0.000748	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Zoledronate—osteoporosis	0.000372	0.000746	CcSEcCtD
Zuclopenthixol—Constipation—Conjugated Estrogens—osteoporosis	0.000372	0.000745	CcSEcCtD
Zuclopenthixol—Pain—Conjugated Estrogens—osteoporosis	0.000372	0.000745	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Zoledronate—osteoporosis	0.000369	0.00074	CcSEcCtD
Zuclopenthixol—Hypertension—Estradiol—osteoporosis	0.000368	0.000738	CcSEcCtD
Zuclopenthixol—Pruritus—Risedronate—osteoporosis	0.000368	0.000737	CcSEcCtD
Zuclopenthixol—Nausea—Calcitriol—osteoporosis	0.000367	0.000735	CcSEcCtD
Zuclopenthixol—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000365	0.000731	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Pamidronate—osteoporosis	0.000364	0.00073	CcSEcCtD
Zuclopenthixol—Myalgia—Estradiol—osteoporosis	0.000363	0.000728	CcSEcCtD
Zuclopenthixol—Anxiety—Estradiol—osteoporosis	0.000362	0.000725	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000361	0.000723	CcSEcCtD
Zuclopenthixol—Discomfort—Estradiol—osteoporosis	0.000359	0.000719	CcSEcCtD
Zuclopenthixol—Abdominal pain—Zoledronate—osteoporosis	0.000357	0.000715	CcSEcCtD
Zuclopenthixol—Body temperature increased—Zoledronate—osteoporosis	0.000357	0.000715	CcSEcCtD
Zuclopenthixol—Diarrhoea—Risedronate—osteoporosis	0.000356	0.000713	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000356	0.000713	CcSEcCtD
Zuclopenthixol—Dry mouth—Estradiol—osteoporosis	0.000355	0.000712	CcSEcCtD
Zuclopenthixol—Asthenia—Pamidronate—osteoporosis	0.000355	0.000711	CcSEcCtD
Zuclopenthixol—Dizziness—Ethinyl Estradiol—osteoporosis	0.000353	0.000707	CcSEcCtD
Zuclopenthixol—Pruritus—Pamidronate—osteoporosis	0.00035	0.000701	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Estradiol—osteoporosis	0.000348	0.000697	CcSEcCtD
Zuclopenthixol—Dizziness—Risedronate—osteoporosis	0.000344	0.000689	CcSEcCtD
Zuclopenthixol—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000344	0.000689	CcSEcCtD
Zuclopenthixol—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000344	0.000689	CcSEcCtD
Zuclopenthixol—Shock—Estradiol—osteoporosis	0.000342	0.000686	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Estradiol—osteoporosis	0.000341	0.000684	CcSEcCtD
Zuclopenthixol—Tachycardia—Estradiol—osteoporosis	0.00034	0.000681	CcSEcCtD
Zuclopenthixol—Vomiting—Ethinyl Estradiol—osteoporosis	0.000339	0.00068	CcSEcCtD
Zuclopenthixol—Diarrhoea—Pamidronate—osteoporosis	0.000338	0.000678	CcSEcCtD
Zuclopenthixol—Skin disorder—Estradiol—osteoporosis	0.000338	0.000677	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Estradiol—osteoporosis	0.000336	0.000674	CcSEcCtD
Zuclopenthixol—Rash—Ethinyl Estradiol—osteoporosis	0.000336	0.000674	CcSEcCtD
Zuclopenthixol—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000336	0.000673	CcSEcCtD
Zuclopenthixol—Headache—Ethinyl Estradiol—osteoporosis	0.000334	0.00067	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Zoledronate—osteoporosis	0.000333	0.000667	CcSEcCtD
Zuclopenthixol—Vomiting—Risedronate—osteoporosis	0.000331	0.000663	CcSEcCtD
Zuclopenthixol—Rash—Risedronate—osteoporosis	0.000328	0.000657	CcSEcCtD
Zuclopenthixol—Dermatitis—Risedronate—osteoporosis	0.000328	0.000657	CcSEcCtD
Zuclopenthixol—Dizziness—Pamidronate—osteoporosis	0.000327	0.000655	CcSEcCtD
Zuclopenthixol—Headache—Risedronate—osteoporosis	0.000326	0.000653	CcSEcCtD
Zuclopenthixol—Asthenia—Zoledronate—osteoporosis	0.000324	0.000649	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00032	0.000642	CcSEcCtD
Zuclopenthixol—Pruritus—Zoledronate—osteoporosis	0.000319	0.00064	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000317	0.000635	CcSEcCtD
Zuclopenthixol—Nausea—Ethinyl Estradiol—osteoporosis	0.000317	0.000635	CcSEcCtD
Zuclopenthixol—Insomnia—Estradiol—osteoporosis	0.000315	0.000631	CcSEcCtD
Zuclopenthixol—Vomiting—Pamidronate—osteoporosis	0.000314	0.00063	CcSEcCtD
Zuclopenthixol—Paraesthesia—Estradiol—osteoporosis	0.000312	0.000626	CcSEcCtD
Zuclopenthixol—Asthenia—Conjugated Estrogens—osteoporosis	0.000312	0.000625	CcSEcCtD
Zuclopenthixol—Rash—Pamidronate—osteoporosis	0.000312	0.000625	CcSEcCtD
Zuclopenthixol—Dermatitis—Pamidronate—osteoporosis	0.000311	0.000624	CcSEcCtD
Zuclopenthixol—Dyspnoea—Estradiol—osteoporosis	0.00031	0.000622	CcSEcCtD
Zuclopenthixol—Headache—Pamidronate—osteoporosis	0.00031	0.000621	CcSEcCtD
Zuclopenthixol—Somnolence—Estradiol—osteoporosis	0.000309	0.00062	CcSEcCtD
Zuclopenthixol—Diarrhoea—Zoledronate—osteoporosis	0.000309	0.000619	CcSEcCtD
Zuclopenthixol—Nausea—Risedronate—osteoporosis	0.000309	0.000619	CcSEcCtD
Zuclopenthixol—Pruritus—Conjugated Estrogens—osteoporosis	0.000308	0.000617	CcSEcCtD
Zuclopenthixol—Dyspepsia—Estradiol—osteoporosis	0.000306	0.000614	CcSEcCtD
Zuclopenthixol—Decreased appetite—Estradiol—osteoporosis	0.000303	0.000606	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Estradiol—osteoporosis	0.0003	0.000602	CcSEcCtD
Zuclopenthixol—Fatigue—Estradiol—osteoporosis	0.0003	0.000601	CcSEcCtD
Zuclopenthixol—Dizziness—Zoledronate—osteoporosis	0.000299	0.000598	CcSEcCtD
Zuclopenthixol—Pain—Estradiol—osteoporosis	0.000298	0.000596	CcSEcCtD
Zuclopenthixol—Constipation—Estradiol—osteoporosis	0.000298	0.000596	CcSEcCtD
Zuclopenthixol—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000298	0.000596	CcSEcCtD
Zuclopenthixol—Nausea—Pamidronate—osteoporosis	0.000294	0.000589	CcSEcCtD
Zuclopenthixol—Dizziness—Conjugated Estrogens—osteoporosis	0.000288	0.000576	CcSEcCtD
Zuclopenthixol—Vomiting—Zoledronate—osteoporosis	0.000287	0.000575	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Estradiol—osteoporosis	0.000287	0.000575	CcSEcCtD
Zuclopenthixol—Rash—Zoledronate—osteoporosis	0.000285	0.000571	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Estradiol—osteoporosis	0.000285	0.00057	CcSEcCtD
Zuclopenthixol—Dermatitis—Zoledronate—osteoporosis	0.000284	0.00057	CcSEcCtD
Zuclopenthixol—Headache—Zoledronate—osteoporosis	0.000283	0.000567	CcSEcCtD
Zuclopenthixol—Vomiting—Conjugated Estrogens—osteoporosis	0.000276	0.000554	CcSEcCtD
Zuclopenthixol—Abdominal pain—Estradiol—osteoporosis	0.000275	0.000551	CcSEcCtD
Zuclopenthixol—Body temperature increased—Estradiol—osteoporosis	0.000275	0.000551	CcSEcCtD
Zuclopenthixol—Rash—Conjugated Estrogens—osteoporosis	0.000274	0.000549	CcSEcCtD
Zuclopenthixol—Dermatitis—Conjugated Estrogens—osteoporosis	0.000274	0.000549	CcSEcCtD
Zuclopenthixol—Headache—Conjugated Estrogens—osteoporosis	0.000272	0.000546	CcSEcCtD
Zuclopenthixol—Nausea—Zoledronate—osteoporosis	0.000268	0.000538	CcSEcCtD
Zuclopenthixol—Nausea—Conjugated Estrogens—osteoporosis	0.000258	0.000518	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Estradiol—osteoporosis	0.000256	0.000514	CcSEcCtD
Zuclopenthixol—Asthenia—Estradiol—osteoporosis	0.00025	0.0005	CcSEcCtD
Zuclopenthixol—Pruritus—Estradiol—osteoporosis	0.000246	0.000493	CcSEcCtD
Zuclopenthixol—Diarrhoea—Estradiol—osteoporosis	0.000238	0.000477	CcSEcCtD
Zuclopenthixol—Dizziness—Estradiol—osteoporosis	0.00023	0.000461	CcSEcCtD
Zuclopenthixol—Vomiting—Estradiol—osteoporosis	0.000221	0.000443	CcSEcCtD
Zuclopenthixol—Rash—Estradiol—osteoporosis	0.000219	0.00044	CcSEcCtD
Zuclopenthixol—Dermatitis—Estradiol—osteoporosis	0.000219	0.000439	CcSEcCtD
Zuclopenthixol—Headache—Estradiol—osteoporosis	0.000218	0.000437	CcSEcCtD
Zuclopenthixol—Nausea—Estradiol—osteoporosis	0.000207	0.000414	CcSEcCtD
Zuclopenthixol—CYP2D6—Metabolism—CA2—osteoporosis	4.75e-05	0.000548	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—OXCT1—osteoporosis	4.75e-05	0.000548	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—GAPDH—osteoporosis	4.74e-05	0.000547	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—FGB—osteoporosis	4.71e-05	0.000544	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TLN1—osteoporosis	4.68e-05	0.00054	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—MGLL—osteoporosis	4.63e-05	0.000534	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—RAP1A—osteoporosis	4.62e-05	0.000533	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—PSMA2—osteoporosis	4.55e-05	0.000525	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—PSMA5—osteoporosis	4.55e-05	0.000525	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—ADCY5—osteoporosis	4.54e-05	0.000524	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—P4HB—osteoporosis	4.51e-05	0.000521	CbGpPWpGaD
Zuclopenthixol—DRD2—Circadian rythm related genes—IL6—osteoporosis	4.49e-05	0.000519	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—KL—osteoporosis	4.47e-05	0.000516	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—P4HB—osteoporosis	4.44e-05	0.000512	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—P4HB—osteoporosis	4.43e-05	0.000511	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—SPP1—osteoporosis	4.39e-05	0.000507	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PTH—osteoporosis	4.39e-05	0.000506	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—POMC—osteoporosis	4.36e-05	0.000503	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—P4HB—osteoporosis	4.34e-05	0.000502	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PTH—osteoporosis	4.32e-05	0.000498	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—RAP1A—osteoporosis	4.31e-05	0.000498	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PTH—osteoporosis	4.31e-05	0.000497	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CNR2—osteoporosis	4.28e-05	0.000494	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—IL6R—osteoporosis	4.25e-05	0.000491	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—IGF1—osteoporosis	4.25e-05	0.000491	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—ADCY5—osteoporosis	4.24e-05	0.00049	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—RAP1A—osteoporosis	4.24e-05	0.00049	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CALCA—osteoporosis	4.24e-05	0.000489	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—RAP1A—osteoporosis	4.23e-05	0.000489	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PTH—osteoporosis	4.23e-05	0.000488	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CNR2—osteoporosis	4.21e-05	0.000486	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—NFATC1—osteoporosis	4.21e-05	0.000486	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CNR2—osteoporosis	4.2e-05	0.000485	CbGpPWpGaD
Zuclopenthixol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	4.19e-05	0.000483	CbGpPWpGaD
Zuclopenthixol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	4.18e-05	0.000482	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—ADCY5—osteoporosis	4.18e-05	0.000482	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—DKK1—osteoporosis	4.17e-05	0.000482	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—ADCY5—osteoporosis	4.17e-05	0.000481	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—RAP1A—osteoporosis	4.15e-05	0.000479	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—NFATC1—osteoporosis	4.14e-05	0.000478	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—POMC—osteoporosis	4.13e-05	0.000477	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—NFATC1—osteoporosis	4.13e-05	0.000477	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CNR2—osteoporosis	4.12e-05	0.000475	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—DKK1—osteoporosis	4.11e-05	0.000474	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	4.1e-05	0.000473	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—DKK1—osteoporosis	4.1e-05	0.000473	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—ADCY5—osteoporosis	4.09e-05	0.000472	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—NFATC1—osteoporosis	4.05e-05	0.000468	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—P4HB—osteoporosis	4.04e-05	0.000466	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—DKK1—osteoporosis	4.02e-05	0.000464	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—WNT1—osteoporosis	4.02e-05	0.000464	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IRS2—osteoporosis	3.97e-05	0.000458	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—WNT1—osteoporosis	3.95e-05	0.000457	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—WNT1—osteoporosis	3.95e-05	0.000456	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—IDH2—osteoporosis	3.94e-05	0.000454	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PTH—osteoporosis	3.93e-05	0.000453	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—FGA—osteoporosis	3.91e-05	0.000451	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—LEP—osteoporosis	3.89e-05	0.000449	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—WNT1—osteoporosis	3.87e-05	0.000447	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—RAP1A—osteoporosis	3.86e-05	0.000446	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—ADCY5—osteoporosis	3.85e-05	0.000445	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—KL—osteoporosis	3.85e-05	0.000444	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—FGA—osteoporosis	3.85e-05	0.000444	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—FGA—osteoporosis	3.84e-05	0.000443	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CNR2—osteoporosis	3.83e-05	0.000442	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—ADCY5—osteoporosis	3.8e-05	0.000439	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—ADCY5—osteoporosis	3.79e-05	0.000438	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—ADCY5—osteoporosis	3.78e-05	0.000437	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—FGA—osteoporosis	3.77e-05	0.000435	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—NFATC1—osteoporosis	3.76e-05	0.000435	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—POMC—osteoporosis	3.75e-05	0.000433	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—DKK1—osteoporosis	3.74e-05	0.000431	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—ENO1—osteoporosis	3.73e-05	0.000431	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—ADCY5—osteoporosis	3.71e-05	0.000429	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—ESR1—osteoporosis	3.71e-05	0.000428	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—CYP27A1—osteoporosis	3.7e-05	0.000427	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PSMA5—osteoporosis	3.68e-05	0.000424	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PSMA2—osteoporosis	3.68e-05	0.000424	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—IL6R—osteoporosis	3.66e-05	0.000423	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PTHLH—osteoporosis	3.63e-05	0.00042	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—BMP2—osteoporosis	3.63e-05	0.00042	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—ACP5—osteoporosis	3.6e-05	0.000415	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—WNT1—osteoporosis	3.6e-05	0.000415	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PTHLH—osteoporosis	3.58e-05	0.000413	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—BMP2—osteoporosis	3.58e-05	0.000413	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PTHLH—osteoporosis	3.57e-05	0.000412	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—BMP2—osteoporosis	3.57e-05	0.000412	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—FGB—osteoporosis	3.56e-05	0.000411	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—ADCY5—osteoporosis	3.5e-05	0.000404	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PTHLH—osteoporosis	3.5e-05	0.000404	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—BMP2—osteoporosis	3.5e-05	0.000404	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—FGA—osteoporosis	3.5e-05	0.000404	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—FGB—osteoporosis	3.5e-05	0.000404	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—FGB—osteoporosis	3.49e-05	0.000403	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IRS1—osteoporosis	3.47e-05	0.0004	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—ADCY5—osteoporosis	3.45e-05	0.000398	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PSMA2—osteoporosis	3.43e-05	0.000396	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PSMA5—osteoporosis	3.43e-05	0.000396	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—FGB—osteoporosis	3.43e-05	0.000396	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—SPP1—osteoporosis	3.39e-05	0.000391	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PSMA2—osteoporosis	3.38e-05	0.00039	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PSMA5—osteoporosis	3.38e-05	0.00039	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PSMA5—osteoporosis	3.37e-05	0.000389	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PSMA2—osteoporosis	3.37e-05	0.000389	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—TPI1—osteoporosis	3.35e-05	0.000386	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—POMC—osteoporosis	3.34e-05	0.000385	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PSMA5—osteoporosis	3.31e-05	0.000382	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PSMA2—osteoporosis	3.31e-05	0.000382	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IL6R—osteoporosis	3.26e-05	0.000376	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PTHLH—osteoporosis	3.25e-05	0.000376	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—BMP2—osteoporosis	3.25e-05	0.000376	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IGF1—osteoporosis	3.21e-05	0.000371	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CALCA—osteoporosis	3.2e-05	0.000369	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—FGB—osteoporosis	3.18e-05	0.000368	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CALCA—osteoporosis	3.15e-05	0.000364	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—P4HB—osteoporosis	3.15e-05	0.000363	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CALCA—osteoporosis	3.14e-05	0.000363	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—POMC—osteoporosis	3.12e-05	0.00036	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GAPDH—osteoporosis	3.09e-05	0.000356	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CALCA—osteoporosis	3.08e-05	0.000356	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PSMA5—osteoporosis	3.07e-05	0.000355	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PSMA2—osteoporosis	3.07e-05	0.000355	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—POMC—osteoporosis	3.07e-05	0.000355	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—POMC—osteoporosis	3.06e-05	0.000354	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IRS2—osteoporosis	3.06e-05	0.000354	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—ADCY5—osteoporosis	3.02e-05	0.000348	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—RAP1A—osteoporosis	3.01e-05	0.000347	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—POMC—osteoporosis	3.01e-05	0.000347	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—LEP—osteoporosis	3e-05	0.000346	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—CYP19A1—osteoporosis	2.98e-05	0.000344	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—SPP1—osteoporosis	2.92e-05	0.000337	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—KL—osteoporosis	2.91e-05	0.000335	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CALCA—osteoporosis	2.86e-05	0.000331	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—ESR1—osteoporosis	2.86e-05	0.000331	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—KL—osteoporosis	2.86e-05	0.00033	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—KL—osteoporosis	2.85e-05	0.000329	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—POMC—osteoporosis	2.83e-05	0.000327	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—KL—osteoporosis	2.8e-05	0.000323	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—POMC—osteoporosis	2.79e-05	0.000323	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—POMC—osteoporosis	2.79e-05	0.000322	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—POMC—osteoporosis	2.78e-05	0.000321	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—IL6R—osteoporosis	2.76e-05	0.000319	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—POMC—osteoporosis	2.73e-05	0.000315	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—IL6R—osteoporosis	2.72e-05	0.000314	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—IL6R—osteoporosis	2.71e-05	0.000313	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IRS1—osteoporosis	2.68e-05	0.000309	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—IL6R—osteoporosis	2.66e-05	0.000308	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IRS2—osteoporosis	2.64e-05	0.000305	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—KL—osteoporosis	2.6e-05	0.0003	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—LEP—osteoporosis	2.58e-05	0.000298	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—POMC—osteoporosis	2.58e-05	0.000297	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—TGFB1—osteoporosis	2.55e-05	0.000294	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—POMC—osteoporosis	2.54e-05	0.000293	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IL6R—osteoporosis	2.51e-05	0.00029	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IGF1—osteoporosis	2.48e-05	0.000286	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	2.48e-05	0.000286	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—ESR1—osteoporosis	2.46e-05	0.000285	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—IL6—osteoporosis	2.46e-05	0.000283	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—ADCY5—osteoporosis	2.44e-05	0.000281	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—ENO1—osteoporosis	2.43e-05	0.000281	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—GPX1—osteoporosis	2.43e-05	0.00028	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PSMA2—osteoporosis	2.4e-05	0.000277	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PSMA5—osteoporosis	2.4e-05	0.000277	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IRS1—osteoporosis	2.3e-05	0.000266	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—ADCY5—osteoporosis	2.28e-05	0.000263	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—MTHFR—osteoporosis	2.24e-05	0.000259	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—ADCY5—osteoporosis	2.24e-05	0.000259	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—ADCY5—osteoporosis	2.24e-05	0.000258	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—POMC—osteoporosis	2.22e-05	0.000256	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—SPP1—osteoporosis	2.2e-05	0.000254	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	2.19e-05	0.000253	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—SPP1—osteoporosis	2.17e-05	0.00025	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IL6R—osteoporosis	2.16e-05	0.00025	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—SPP1—osteoporosis	2.16e-05	0.00025	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IGF1—osteoporosis	2.13e-05	0.000246	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—SPP1—osteoporosis	2.12e-05	0.000245	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	2.04e-05	0.000235	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IRS2—osteoporosis	1.99e-05	0.00023	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—SPP1—osteoporosis	1.97e-05	0.000228	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IRS2—osteoporosis	1.96e-05	0.000226	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IRS2—osteoporosis	1.96e-05	0.000226	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—LEP—osteoporosis	1.95e-05	0.000225	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.94e-05	0.000224	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—MYC—osteoporosis	1.93e-05	0.000223	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—TGFB1—osteoporosis	1.92e-05	0.000222	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IRS2—osteoporosis	1.92e-05	0.000222	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—LEP—osteoporosis	1.92e-05	0.000221	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—LEP—osteoporosis	1.91e-05	0.000221	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—IL6—osteoporosis	1.9e-05	0.000219	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—LEP—osteoporosis	1.88e-05	0.000217	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—ESR1—osteoporosis	1.86e-05	0.000215	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—ESR1—osteoporosis	1.83e-05	0.000211	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—ESR1—osteoporosis	1.83e-05	0.000211	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—ESR1—osteoporosis	1.79e-05	0.000207	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—POMC—osteoporosis	1.79e-05	0.000207	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IRS2—osteoporosis	1.78e-05	0.000206	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—LEP—osteoporosis	1.74e-05	0.000201	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IRS1—osteoporosis	1.74e-05	0.000201	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IRS1—osteoporosis	1.71e-05	0.000197	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IRS1—osteoporosis	1.71e-05	0.000197	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IRS1—osteoporosis	1.68e-05	0.000193	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—POMC—osteoporosis	1.67e-05	0.000193	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—ESR1—osteoporosis	1.67e-05	0.000192	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—POMC—osteoporosis	1.65e-05	0.00019	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—POMC—osteoporosis	1.64e-05	0.00019	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IL6R—osteoporosis	1.63e-05	0.000189	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—IL6—osteoporosis	1.63e-05	0.000188	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—POMC—osteoporosis	1.61e-05	0.000186	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IGF1—osteoporosis	1.61e-05	0.000186	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IL6R—osteoporosis	1.61e-05	0.000186	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IL6R—osteoporosis	1.6e-05	0.000185	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—ADCY5—osteoporosis	1.59e-05	0.000183	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IGF1—osteoporosis	1.58e-05	0.000183	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GPX1—osteoporosis	1.58e-05	0.000183	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IGF1—osteoporosis	1.58e-05	0.000183	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IL6R—osteoporosis	1.57e-05	0.000182	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IRS1—osteoporosis	1.56e-05	0.00018	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IGF1—osteoporosis	1.55e-05	0.000179	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—POMC—osteoporosis	1.5e-05	0.000173	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—MYC—osteoporosis	1.49e-05	0.000172	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TGFB1—osteoporosis	1.49e-05	0.000171	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL6R—osteoporosis	1.46e-05	0.000169	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—MTHFR—osteoporosis	1.46e-05	0.000169	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IL6—osteoporosis	1.45e-05	0.000167	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IGF1—osteoporosis	1.44e-05	0.000166	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—MYC—osteoporosis	1.28e-05	0.000148	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TGFB1—osteoporosis	1.28e-05	0.000148	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—IL6—osteoporosis	1.23e-05	0.000142	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—IL6—osteoporosis	1.21e-05	0.00014	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—IL6—osteoporosis	1.21e-05	0.00014	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—IL6—osteoporosis	1.19e-05	0.000137	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—POMC—osteoporosis	1.17e-05	0.000135	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IL6—osteoporosis	1.12e-05	0.000129	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—IL6—osteoporosis	1.1e-05	0.000127	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—MYC—osteoporosis	9.68e-06	0.000112	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TGFB1—osteoporosis	9.66e-06	0.000111	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IL6—osteoporosis	9.64e-06	0.000111	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—MYC—osteoporosis	9.52e-06	0.00011	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—MYC—osteoporosis	9.5e-06	0.00011	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TGFB1—osteoporosis	9.5e-06	0.00011	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TGFB1—osteoporosis	9.48e-06	0.000109	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—MYC—osteoporosis	9.33e-06	0.000108	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	9.3e-06	0.000107	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—MYC—osteoporosis	8.66e-06	0.0001	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	8.64e-06	9.98e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IL6—osteoporosis	7.28e-06	8.4e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IL6—osteoporosis	7.16e-06	8.26e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IL6—osteoporosis	7.14e-06	8.25e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IL6—osteoporosis	7.01e-06	8.09e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL6—osteoporosis	6.51e-06	7.52e-05	CbGpPWpGaD
